Abner Herrman & Brock’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Abner Herrman & Brock's GILD Position: Q4 2019 in Review
Abner Herrman & Brock sold out of Gilead Sciences (GILD) in Q4 2019, closing a stake of 7,108 shares — an estimated $451K sold.
Abner Herrman & Brock first reported a position in GILD in Q2 2013 and held it in 26 quarters. The position peaked at $1.16M in Q2 2015. 1,555 funds tracked by Wall St. Rank hold GILD as of Q4 2019.
- Abner Herrman & Brock reported no remaining Gilead Sciences position as of Q4 2019 after selling out during the quarter.
- Abner Herrman & Brock sold 7,108 Gilead Sciences shares in Q4 2019, an estimated $451K.
- Abner Herrman & Brock first reported a position in Gilead Sciences in Q2 2013 and held it in 26 quarters.
- Abner Herrman & Brock's Gilead Sciences position peaked at $1.16M in Q2 2015.
- 1,555 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2019.
Based on Abner Herrman & Brock's 13F filing for Q4 2019, filed 10 Jan 2020.